Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
87.08 USD | -0.23% |
|
-12.33% | -12.06% |
06:09am | TD Cowen Downgrades Merck & Co. to Hold From Buy, Adjusts Price Target to $100 From $121 | MT |
Feb. 07 | Health Rounds: Vaccine keeps advanced kidney cancer from recurring | RE |
- Stock Market
- Equities
- MRK Stock
- News Merck & Co., Inc.
- Other languages